Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?

BACKGROUND: Despite differences in types of infection and causative organisms, pharmacokinetic-pharmacodynamic (PKPD) targets of vancomycin therapy derived from adult studies are suggested for neonates. We aimed to identify doses needed for the attainment of AUC/MIC > 400 and AUC/MIC > 300 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Padari, Helgi, Oselin, Kersti, Tasa, Tõnis, Metsvaht, Tuuli, Lõivukene, Krista, Lutsar, Irja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146818/
https://www.ncbi.nlm.nih.gov/pubmed/27931193
http://dx.doi.org/10.1186/s12887-016-0753-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146818/
https://www.ncbi.nlm.nih.gov/pubmed/27931193
http://dx.doi.org/10.1186/s12887-016-0753-0

Ejemplares similares